Sodium Oxybate 65162-0065-87
- Manufacturer
- Amneal Pharmaceuticals Llc
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 12, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA203631
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sodium Oxybate | 500 mg/mL |
Drug Class
Central Nervous System Depressant [EPC]Central Nervous System Depression [PE]Decreased Central Nervous System Organized Electrical Activity [PE]
Selected Package
65162-0065-87Selected1 BOTTLE in 1 CARTON (65162-065-87) / 180 mL in 1 BOTTLE